- Home
- SPGC vs KTTA Comparison
SPGC vs KTTA Comparison
Compare SPGC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPGC
- KTTA
- Stock Information
- Founded
- SPGC 2018
- KTTA 2020
- Country
- SPGC United States
- KTTA United States
- Employees
- SPGC N/A
- KTTA N/A
- Industry
- SPGC
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- SPGC
- KTTA Health Care
- Exchange
- SPGC Nasdaq
- KTTA Nasdaq
- Market Cap
- SPGC 3.6M
- KTTA 3.5M
- IPO Year
- SPGC 2023
- KTTA 2021
- Fundamental
- Price
- SPGC $1.66
- KTTA $3.38
- Analyst Decision
- SPGC
- KTTA
- Analyst Count
- SPGC 0
- KTTA 0
- Target Price
- SPGC N/A
- KTTA N/A
- AVG Volume (30 Days)
- SPGC 102.7K
- KTTA 29.8K
- Earning Date
- SPGC 11-14-2024
- KTTA 11-13-2024
- Dividend Yield
- SPGC N/A
- KTTA N/A
- EPS Growth
- SPGC N/A
- KTTA N/A
- EPS
- SPGC N/A
- KTTA N/A
- Revenue
- SPGC $2,491,000.00
- KTTA N/A
- Revenue This Year
- SPGC $771.92
- KTTA N/A
- Revenue Next Year
- SPGC $76.31
- KTTA N/A
- P/E Ratio
- SPGC N/A
- KTTA N/A
- Revenue Growth
- SPGC 840.00
- KTTA N/A
- 52 Week Low
- SPGC $1.52
- KTTA $3.19
- 52 Week High
- SPGC $9.17
- KTTA $17.40
- Technical
- Relative Strength Index (RSI)
- SPGC 34.00
- KTTA 38.62
- Support Level
- SPGC $1.61
- KTTA $3.20
- Resistance Level
- SPGC $2.07
- KTTA $3.46
- Average True Range (ATR)
- SPGC 0.16
- KTTA 0.35
- MACD
- SPGC 0.03
- KTTA -0.01
- Stochastic Oscillator
- SPGC 10.98
- KTTA 16.38
About SPGC Sacks Parente Golf Inc.
Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.